Durvalumab-induced Organizing Pneumonia with a Diffuse Micronodular Pattern in a Patient with Lung Cancer

Am J Respir Crit Care Med. 2020 Apr 15;201(8):e52-e53. doi: 10.1164/rccm.201907-1310IM.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Bronchoscopy
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Chemoradiotherapy
  • Cryptogenic Organizing Pneumonia / chemically induced*
  • Cryptogenic Organizing Pneumonia / diagnostic imaging
  • Cryptogenic Organizing Pneumonia / drug therapy
  • Cryptogenic Organizing Pneumonia / pathology
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Maintenance Chemotherapy
  • Male
  • Neoplasm Staging
  • Tomography, X-Ray Computed

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological
  • durvalumab